The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.

Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a ...

Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...